SCHEMBL7323231

SCHEMBL7323231

Clc1cc(CCc2ccccn2)c2oc(-c3cccs3)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 6/20 0.43
NTRK3 Q16288 3/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
HPGD P15428 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
F2 P00734 1/20 0.39
SYK P43405 1/20 0.39
MAPT P10636 5/20 0.39
NPC1 O15118 3/20 0.39
TP53 P04637 3/20 0.39
RAB9A P51151 3/20 0.39
HSD17B10 Q99714 2/20 0.39
GFER P55789 1/20 0.39
PDE4C Q08493 1/20 0.39
GBA1 P04062 1/20 0.38
PKM P14618 1/20 0.37
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322971 0.84 NPC1 (0.41) ALDH1A1KDM4ESMN1; SMN2HPGDMAPT
SCHEMBL7324750 0.84 STAT6 (0.38) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL7318937 0.83 CHRNA7 (0.38) ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A
SCHEMBL7315804 0.80 ALDH1A1 (0.36) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL7325321 0.80 ADORA2A (0.49) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL7317091 0.80 PDGFRB (0.38) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL7324311 0.80 KDM4E (0.40) ALDH1A1KDM4ESMN1; SMN2HPGDMAPT
SCHEMBL7315751 0.80 RAB9A (0.43) ALDH1A1KDM4ESMN1; SMN2HPGDNPC1
SCHEMBL7314123 0.80 KDM4E (0.37) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL7324755 0.79 ALDH1A1 (0.37) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US claimed
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US disclosed